The deal includes the payment of an upfront consideration of $425m for the company, which is developing a compound to alleviate menopausal symptoms
Life sciences VCs sell British drug maker KaNDy Therapeutics to Bayer
Most Popular
The deal includes the payment of an upfront consideration of $425m for the company, which is developing a compound to alleviate menopausal symptoms